CoChat

Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation

Open access
Schlaepfer, Isabel R., Nambiar, Dhanya K., Ramteke, Anand, Kumar, Rahul, Dhar, Deepanshi, Agarwal, Chapla, Bergman, Bryan, Graner, Michael, Maroni, Paul, Singh, Rana P., Agarwal, Rajesh, Deep, Gagan · 2015 · Oncotarget
Cited by 109

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

// Isabel R. Schlaepfer 1,* , Dhanya K. Nambiar 2,3,* , Anand Ramteke 2,4,* , Rahul Kumar 2 , Deepanshi Dhar 2 , Chapla Agarwal 2,5 , Bryan Bergman 6 , Michael Graner 7 , Paul Maroni 8 , Rana P. Singh 3 , Rajesh Agarwal 2,5 and Gagan Deep 2,5 1 Division of Medical Oncology, Department of Medicine, University of Colorado Denver, Aurora, Colorado, USA 2 Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, Aurora, Colorado, USA 3 Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India 4 Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, India 5 University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado, USA 6 Division of Endocrinology, Metabolism and Diabetes, University of Colorado Denver, Aurora, Colorado, USA 7 Department of Neurosurgery, University of Colorado Denver, Aurora, Colorado, USA 8 Department of Surgery, University of Colorado Denver, Aurora, Colorado, USA * These authors have contributed equally to this work Correspondence to: Gagan Deep, email: // Rajesh Agarwal, email: // Keywords : hypoxia, extracellular vesicle, prostate cancer, lipids, β-oxidation Received : January 30, 2015 Accepted : May 22, 2015 Published : September 08, 2015 Abstract Hypoxia is an independent prognostic indicator of poor outcome in several malignancies. However, precise mechanism through which hypoxia promotes disease aggressiveness is still unclear. Here, we report that under hypoxia (1% O 2 ), human prostate cancer (PCA) cells, and extracellular vesicles (EVs) released by these cells, are significantly enriched in triglycerides due to the activation of lipogenesis-related enzymes and signaling molecules. This is likely a survival response to hypoxic stress as accumulated lipids could support growth following reoxygenation. Consistent with this, significantly higher proliferation was observed in hypoxic PCA cells following reoxygenation associated with rapid use of accumulated lipids. Importantly, lipid utilization inhibition by CPT1 inhibitor etomoxir and shRNA-mediated CPT1-knockdown significantly compromised hypoxic PCA cell proliferation following reoxygenation. Furthermore, COX2 inhibitor celecoxib strongly reduced growth and invasiveness following hypoxic PCA cells reoxygenation, and inhibited invasiveness induced by hypoxic PCA EVs. This establishes a role for COX2 enzymatic products in the enhanced PCA growth and invasiveness. Importantly, concentration and loading of EVs secreted by PCA cells were significantly compromised under delipidized serum condition and by lipogenesis inhibitors (fatostatin and silibinin). Overall, present study highlights the biological significance of lipid accumulation in hypoxic PCA cells and its therapeutic relevance in PCA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4479

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Schlaepfer, I. R., Nambiar, D. K., Ramteke, A., Kumar, R., Dhar, D., Agarwal, C., Bergman, B., Graner, M., Maroni, P., Singh, R. P., Agarwal, R., & Deep, G.
Venue
Oncotarget
Published
2015-06-15
Volume
6
Issue
26
Pages
22836-22856
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1699517970
Cited by
109
References
6
FWCI
2.26
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.